SB 207266

structure given in first source

Also Known As:

BPMDOIC; N-((1-butyl-4-piperidinyl)methyl)-3,4-dihydro-2H-(1,3)oxazino(3,2-a)indole-10-carboxamide; SB-207266

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Visceral Pain 01/01/2011 - "The inhibitory effect of mosapride on gastric distension-induced visceral pain was partially, but significantly inhibited by SB-207266, a selective 5-HT(4)-receptor antagonist. "
2.	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 08/01/1998 - "SB-207266 is a new 5-HT4 receptor antagonist which in a pilot study reduced the symptoms of irritable bowel syndrome. "